Nanogel‐based scaffold delivery of prostaglandin E₂ receptor–specific agonist in combination with a low dose of growth factor heals critical‐size bone defects in mice

Abstract

These data indicate that combined delivery of EP4A and low-dose BMP-2 via nanogel-based hydrogel provides a new system for bone repair.